Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.22 is 83% below its 5-year average of 7.28, near the low end of its 5-year range (1.22–16.47).
As of the fiscal period ended Tuesday, June 30, 2026. 42.49% below its 12-month average of 2.11.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.22.
QUICK RATIO (ACID-TEST)
1.22
QUICK RATIO (ACID-TEST) AVG TTM
2.11
QUICK RATIO (ACID-TEST) AVG 3Y
4.72
QUICK RATIO (ACID-TEST) AVG 5Y
7.28
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-42.49%
CURRENT VS 3Y AVG
-74.28%
CURRENT VS 5Y AVG
-83.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.28
median of 792 covered companies
CURRENT VS SECTOR MEDIAN
-62.96%
vs the sector median at left
Passage Bio, Inc.
Market Cap
$13.24M
Quick Ratio (Acid-Test)
1.22
TTM Avg
2.11
3Y Avg
4.72
5Y Avg
7.28
Market Cap
$13.51M
Quick Ratio (Acid-Test)
1.69
TTM Avg
0.14
3Y Avg
1.07
5Y Avg
2.78
Market Cap
$13.66M
Quick Ratio (Acid-Test)
4.37
TTM Avg
1.21
3Y Avg
1.25
5Y Avg
1.53
Market Cap
$12.78M
Quick Ratio (Acid-Test)
6.66
TTM Avg
2.77
3Y Avg
1.93
5Y Avg
5.53
Market Cap
$12.77M
Quick Ratio (Acid-Test)
0.50
TTM Avg
1.75
3Y Avg
2.03
5Y Avg
3.39
Market Cap
$13.74M
Quick Ratio (Acid-Test)
0.40
TTM Avg
0.15
3Y Avg
4.02
5Y Avg
6.30
Market Cap
$13.86M
Quick Ratio (Acid-Test)
1.60
TTM Avg
1.72
3Y Avg
1.47
5Y Avg
3.47
Market Cap
$12.52M
Quick Ratio (Acid-Test)
0.99
TTM Avg
0.99
3Y Avg
1.05
5Y Avg
1.43
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Passage Bio, Inc. (PASG) | $13.24M | 1.22 | 2.11 | 4.72 | 7.28 |
| Optimi Health Corp. (OPTH)vs › | $13.51M | 1.69 | 0.14 | 1.07 | 2.78 |
| Vyome Holdings, Inc. (HIND)vs › | $13.66M | 4.37 | 1.21 | 1.25 | 1.53 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.78M | 6.66 | 2.77 | 1.93 | 5.53 |
| Cytosorbents Corporation (CTSO)vs › | $12.77M | 0.50 | 1.75 | 2.03 | 3.39 |
| IN8bio, Inc. (INAB)vs › | $13.71M | 8.21 | 6.45 | 5.32 | 7.60 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.74M | 0.40 | 0.15 | 4.02 | 6.30 |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | 1.60 | 1.72 | 1.47 | 3.47 |
| Dare Bioscience, Inc. (DARE)vs › | $12.52M | 0.99 | 0.99 | 1.05 | 1.43 |
| Lantern Pharma Inc. (LTRN)vs › | $12.24M | 1.96 | 4.12 | 11.35 | 18.88 |
Quick Ratio
1.22
Excludes inventory
Current Ratio
1.22
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.22 |
| 2026-03-31 | 1.73 |
| 2025-12-31 | 2.07 |
| 2025-09-30 | 2.51 |
| 2025-06-30 | 3.05 |
| 2025-03-31 | 3.74 |
| 2024-12-31 | 4.07 |
| 2024-09-30 | 5.15 |
| 2024-06-30 | 7.67 |
| 2024-03-31 | 8.43 |
| 2023-12-31 | 7.22 |
| 2023-09-30 | 6.85 |
| 2023-06-30 | 7.73 |
| 2023-03-31 | 9.95 |
| 2022-12-31 | 10.74 |
| 2022-09-30 | 10.29 |
| 2022-06-30 | 9.24 |
| 2022-03-31 | 10.30 |
| 2021-12-31 | 11.02 |
| 2021-09-30 | 16.47 |
| 2021-06-30 | 13.40 |
| 2021-03-31 | 23.16 |
| 2020-12-31 | 14.98 |
| 2020-09-30 | 18.30 |
| 2020-06-30 | 26.05 |
| 2020-03-31 | 73.09 |
| 2019-12-31 | 45.04 |
| 2019-09-30 | 95.28 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 108.79 |
